Format

Send to

Choose Destination
Mini Rev Med Chem. 2001 May;1(1):43-55.

Small molecule inhibitors of serine/threonine protein phosphatases.

Author information

1
Medicinal Chemistry Group, School of Biological and Chemical Sciences, The University of Newcastle, Callaghan, NSW, Australia 2308. amcclusk@mail.newcastle.edu.au

Abstract

Serine/threonine protein phosphatases have long been ignored as potential therapeutic targets for two reasons, one the biochemical significance of these proteins has not been appreciated and two, many natural protein phosphatase inhibitors are potent toxins and are considered unsuitable for clinical use. This review outlines the biochemical role of this protein family in cancer, cystic fibrosis, immunosuppression and, cardiac and neurological disorders. Particular emphasis is also given to the synthesis of selective small molecule inhibitors and their clinical exploitation.

PMID:
12369990
DOI:
10.2174/1389557013407205
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd.
Loading ...
Support Center